Dr Geoffrey M Shaw

Dr. Geoffrey M. Shaw is a prominent Intensive Care Specialist and clinical researcher based in Christchurch, New Zealand, who operates through his professional entity, Geoffrey Shaw Limited. He is internationally recognized for his work in intensive care medicine, specifically in the development and clinical validation of model-based therapeutics such as the STAR (Stochastic Targeted) glycaemic control protocol. His research focuses on improving patient outcomes in the ICU through the application of engineering principles and mathematical modeling to optimize treatments like insulin dosing and mechanical ventilation. Dr. Shaw holds a professorship at the University of Otago and collaborates extensively with the University of Canterbury's Department of Mechanical Engineering. His work has led to significant advancements in personalized medicine for critically ill patients, with his protocols being adopted in multiple international clinical settings. The entity serves as the primary vehicle for his consultancy and specialized clinical research initiatives.